Skip to main content
. Author manuscript; available in PMC: 2017 Jun 21.
Published in final edited form as: Nature. 2016 Dec 21;541(7635):87–91. doi: 10.1038/nature20790

Extended Data Figure 5. Elevated ADP-ribosylation in XRCC1-/- RPE-1 cells, XRCC1 patient fibroblasts, and PNKP patient fibroblasts.

Extended Data Figure 5

a, ADP-ribosylated proteins were detected in cell extracts from wild type RPE-1 cells (“WT”), XRCC1-/- RPE-1 cells, wild type 1BR fibroblasts, XRCC1 patient fibroblasts (“X1 patient”), and PNKP patient fibroblasts treated as in Fig. 4a by Western blotting and Anti-pan-ADP-ribose binding reagent. b, Levels of ADP-ribosylation in 1BR wild type, XRCC1 patient, and PNKP patient fibroblasts measured before and after CPT treatment by indirect immunofluorescence as indicated in Fig. 4b. Representative ScanR images are shown.

HHS Vulnerability Disclosure